Salesforce (CRM): Oppenheimer Maintains Outperform, Trims PT to $300 Ahead of F3Q Results

Core Viewpoint - Salesforce, Inc. is recognized as a prominent AI stock on Wall Street, with Oppenheimer maintaining an "Outperform" rating but lowering its price target to $300 from $315 due to reduced group multiples [1][3]. Group 1: Company Performance and Outlook - Oppenheimer's optimism is based on Salesforce's long-term positioning in AI, driven by pricing benefits and strong momentum in Agentforce and Data Cloud [2]. - The firm's surveys indicate normal end-of-year customer and IT spending, with low expectations for the upcoming quarter, suggesting limited downside risk [2]. - Analysts noted continued margin growth and the closing of the Informatica deal, which alleviates previous concerns, while an 8% free cash flow yield provides additional downside protection [3]. Group 2: Market Context and Comparisons - Despite acknowledging Salesforce's potential, some analysts believe other AI stocks may offer greater upside potential and lower downside risk [4].